Which ASX ETFs hold REVOLUTION Medicines Inc (RVMD)?
As at Q3 2026, RVMD is among the most widely held stocks across ASX-listed ETFs, appearing in approximately 5 ETFs. Its largest single position is approximately 2.17% in JNDQ (BetaShares NASDAQ Next Gen 100 ETF). General information only, not financial advice.
General information only, not financial advice. ETFLens does not hold an AFSL. Always read the relevant PDS and consider seeking advice from a licensed financial adviser.
All weights are approximate, drawn from each fund's published holdings as at Q3 2026, and change as funds rebalance.
| ETF | Fund | Category | Weight |
|---|---|---|---|
| JNDQ | BetaShares NASDAQ Next Gen 100 ETF | US Shares | approx. 2.17% |
| CURE | Global X S&P Biotech ETF | Thematic | approx. 1.31% |
| VTS | Vanguard US Total Market Shares Index ETF | US Shares | approx. 0.05% |
| VGS | Vanguard MSCI Index International Shares ETF | Global Broad Market | approx. 0.03% |
| VGAD | Vanguard MSCI Index International Shares (Hedged) ETF | Global Broad Market | approx. 0.03% |
Want to see what any of these funds overlap with? Try the free ETF overlap checker, or browse the most widely held stocks.
Hold more than one of these? See your combined RVMD exposure across all your ETFs with the Stock X-Ray.
RVMD in ETFs: frequently asked questions
Which ASX ETFs hold RVMD?
REVOLUTION Medicines Inc (RVMD) is held by approximately 5 ASX-listed ETFs, including JNDQ, CURE, VTS, VGS, VGAD. General information only.
Which ETF has the largest RVMD weighting?
JNDQ (BetaShares NASDAQ Next Gen 100 ETF) has the largest RVMD position at approximately 2.17% of the fund, as at Q3 2026. Past weightings are not a reliable indicator of future weightings.